FDA Drug · D-0847-2026

Prasugrel HCI, Tablets, USP, 10mg, 30-count bottle, Rx only, Marketed by: GSMS, Incorporated, Camarillo, CA 93012, USA, NDC: 51407-445-30.

Class II · Ongoing

Failed Dissolution Specifications. Notification from the manufacturer that lot is being recalled due to failed dissolution

Affected lots / codes — check yours against thisLot # GS062298, Exp Date: 09/30/ 2026.

Recalling firm: Golden State Medical Supply Inc., Camarillo, CA
Classification: Class II (temporary or reversible harm possible)
Status: Ongoing
Quantity: 6791 30-count bottles
Distribution: US Nationwide.
Recall initiated: August 21, 2026
Classified: September 15, 2026
Initiation: Voluntary: Firm initiated

Official source. This record is published by the U.S. FDA through the openFDA enforcement database. View the unmodified government record:
https://api.fda.gov/drug/enforcement.json?search=recall_number%3A%22D-0847-2026%22

Important. Recalls target specific lots and codes — compare the affected lots above against your own product. This page reproduces public FDA data for readability; EveryRecall is independent and not affiliated with the FDA.

Check this brand across all 8 databases →